BELLUS Health Inc. - Common Shares (NQ:BLU)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BELLUS Health Inc. - Common Shares

< Previous 1 2 3 4 Next >

Why Is ContraFect (CFRX) Stock Down 14% Today? ↗

April 18, 2023

ContraFect (CFRX) stock is dropping on Tuesday after the company revealed a notice from the Nasdaq Exchange and undergoing a rally yesterday.

Via InvestorPlace

Why Is Bellus Health (BLU) Stock Up 98% Today? ↗

April 18, 2023

Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).

Via InvestorPlace

Why Digital Brands Group Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket ↗

April 18, 2023

Gainers Super League Gaming, Inc. (NASDAQ: SLGG) jumped 119.8% to $0.9408 in pre-market trading. LandVault and Super League disclosed a strategic partnership to provide brands with scalable solutions...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 18, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

Via InvestorPlace

BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US ↗

July 13, 2022

Via Benzinga

BELLUS Health Announces FDA End-of-Phase 2 Meeting For Refractory Chronic Cough Program ↗

July 12, 2022

Via Benzinga

BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session ↗

April 18, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

GSK To Strengthen Specialty Medicines and Respiratory Pipeline With $2B BELLUS Health Acquisition ↗

April 18, 2023

Via Benzinga

BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation

April 05, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Year 2022 Financial Results and Business Highlights

March 21, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in the Cowen 43rd Annual Health Care Conference

March 01, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present on the Patient Experience and the Burden of Refractory Chronic Cough at the American Academy of Allergy, Asthma & Immunology Annual Meeting

February 08, 2023

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights

November 14, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences

November 10, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting

October 10, 2022

From BELLUS Health Inc.

Via Business Wire

Expert Ratings for BELLUS Health ↗

September 30, 2022

Over the past 3 months, 4 analysts have published their opinion on BELLUS Health (NASDAQ:BLU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

BELLUS Health to Present at the H.C. Wainwright Global Investment Conference

September 06, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the European Respiratory Society International Congress 2022

August 22, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights

August 10, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States

July 18, 2022

From BELLUS Health Inc.

Via Business Wire

Here's Why BELLUS Health Shares Are Diving Lower Today ↗

July 14, 2022

BELLUS Health Inc (NASDAQ: BLU) shares are trading lower by 10.80% to $9.00 Thursday morning after the company priced an offering of 16,540,541 shares at a price of $9.25 per share.

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

U.S. Stock Futures Down Ahead Of Bank Earnings, Producer Price Index ↗

July 14, 2022

Pre-open movers

Via Benzinga

BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States

July 13, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States

July 13, 2022

From BELLUS Health Inc.

Via Business Wire

Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough

July 12, 2022

From BELLUS Health Inc.

Via Business Wire

BELLUS Health to Participate in the William Blair Biotech Focus Conference

July 05, 2022

From BELLUS Health Inc.

Via Business Wire

The Week In Charts: How To Make Money While Waiting For Core Trend Trades ↗

July 02, 2022

The real money is in the longer-term core trend trades. However, sometimes those opportunities can be few and far between. This is especially true in a bear market.

Via Talk Markets

4 Biotech Stocks With Bright Prospects To Buy Amid Recovery ↗

June 11, 2022

New drug approvals, acquisitions, and other pipeline developments are back in the spotlight in the biotech industry, following the focus on the development of vaccines and antibody treatments for...

Via Talk Markets

BELLUS Health to Participate in the Jefferies Healthcare Conference

June 01, 2022

From BELLUS Health Inc.

Via Business Wire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.